Anti-inflammatory effects of siponimod on astrocytes

Siponimod, which is approved to treat active secondary progressive multiple sclerosis, acts as a functional antagonist of sphingosine-1-phosphate (S1P) receptor 1 (S1P1) and an agonist of S1P5. S1P1 antagonization, which inhibits lymphocyte egress from lymphoid tissues and subsequent infiltration in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience research 2022-11, Vol.184, p.38-46
Hauptverfasser: Ogasawara, Akihiro, Takeuchi, Hideyuki, Komiya, Hiroyasu, Ogawa, Yuki, Nishimura, Koki, Kubota, Shun, Hashiguchi, Shunta, Takahashi, Keita, Kunii, Misako, Tanaka, Kenichi, Tada, Mikiko, Doi, Hiroshi, Tanaka, Fumiaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!